Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

ACVBP Plus Rituximab Versus CHOP Plus Rituximab in Patients With Diffuse Large B-cell Lymphoma and Age-adjusted IPI of 1

This study has been completed.
Information provided by:
Lymphoma Study Association Identifier:
First received: August 31, 2005
Last updated: March 3, 2011
Last verified: March 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2009
  Primary Completion Date: January 2009 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):